Price-Fixing Investigation: Patients Say They Couldn’t Afford Crucial Psychiatric Drug After Generic Companies Hiked Cost

Patients say a month's supply of a drug called clomipramine suddenly jumped from $16 to $348. Taro Pharmaceuticals Industries Ltd., Mylan Pharmaceuticals Inc. and Novartis AG's generics arm, Sandoz, are facing a court challenge over accusations that they conspired to raise the drug's price in unison. The allegation is part of a sweeping lawsuit that names 20 generic drugmakers and subsidiaries in all. In other pharmaceutical news: fish-oil drugs, chemo-free medication, and insulin.

from Kaiser Health News https://ift.tt/2MvXJwh